165 related articles for article (PubMed ID: 27074084)
21. [Anti-MOG immunoglobulin IgM].
Fukaura H; Kikuchi S
Nihon Rinsho; 2005 Jul; 63 Suppl 7():593-5. PubMed ID: 16111341
[No Abstract] [Full Text] [Related]
22. [Serum antibodies against brain tissue in multiple sclerosis patients: a frequent phenomenon in chronic progressive, but not relapsing disease course].
Henneberg A; Mayle DM; Pfau JU; Hartmann P; Elsner U; Kornhuber HH
Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):593-6. PubMed ID: 7856267
[No Abstract] [Full Text] [Related]
23. Autoantibodies to the proteasome in monosymptomatic optic neuritis may predict progression to multiple sclerosis.
Beyer NH; Milthers J; Bonde Lauridsen AM; Houen G; Lautrup Frederiksen J
Scand J Clin Lab Invest; 2007; 67(7):696-706. PubMed ID: 17852796
[TBL] [Abstract][Full Text] [Related]
24. Antibodies to myelin oligodendrocyte glycoprotein as a biomarker in multiple sclerosis--are we there yet?
Amor S; Giovannoni G
Mult Scler; 2007 Nov; 13(9):1083-5. PubMed ID: 17967836
[No Abstract] [Full Text] [Related]
25. KIR4.1: another misleading expectation in multiple sclerosis?
Filippi M; Rocca MA; Lassmann H
Lancet Neurol; 2014 Aug; 13(8):753-5. PubMed ID: 25008547
[No Abstract] [Full Text] [Related]
26. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.
Hayakawa S; Mori M; Okuta A; Kamegawa A; Fujiyoshi Y; Yoshiyama Y; Mitsuoka K; Ishibashi K; Sasaki S; Hattori T; Kuwabara S
J Neuroimmunol; 2008 May; 196(1-2):181-7. PubMed ID: 18462810
[TBL] [Abstract][Full Text] [Related]
27. Conformation-activity relationship of designed glycopeptides as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosis.
Carotenuto A; D'Ursi AM; Mulinacci B; Paolini I; Lolli F; Papini AM; Novellino E; Rovero P
J Med Chem; 2006 Aug; 49(17):5072-9. PubMed ID: 16913697
[TBL] [Abstract][Full Text] [Related]
28. Presence of aberrant VH6 domains in anti-interferon-γ autoantibodies in multiple sclerosis.
Tyumentseva MA; Morozova VV; Lebedev LR; Babkin IV; Tikunova NV
Hum Antibodies; 2013; 22(1-2):31-49. PubMed ID: 24284307
[TBL] [Abstract][Full Text] [Related]
29. Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4.
Kim W; Lee JE; Li XF; Kim SH; Han BG; Lee BI; Kim JK; Choi K; Kim HJ
Mult Scler; 2012 May; 18(5):578-86. PubMed ID: 21965418
[TBL] [Abstract][Full Text] [Related]
30. Antimyelin antibodies in multiple sclerosis.
Maguire GA
N Engl J Med; 2003 Dec; 349(23):2269-71; author reply 2269-71. PubMed ID: 14657439
[No Abstract] [Full Text] [Related]
31. Antimyelin antibodies with no progression to multiple sclerosis.
Pelayo R; Tintoré M; Montalban X; Rovira A; Espejo C; Reindl M; Berger T
N Engl J Med; 2007 Jan; 356(4):426-8. PubMed ID: 17251547
[No Abstract] [Full Text] [Related]
32. Detection of antibodies to the 20s proteasome by ELISA.
Jørgensen KM; Frederiksen JL; Nielsen CT; Houen G
J Immunoassay Immunochem; 2013; 34(4):384-92. PubMed ID: 23859789
[TBL] [Abstract][Full Text] [Related]
33. Proteasome antibodies in patients with cancer or multiple sclerosis.
Thuy-Tien H; Haugen M; Aarseth J; Storstein A; Vedeler CA
Scand J Immunol; 2008 Apr; 67(4):400-3. PubMed ID: 18266796
[TBL] [Abstract][Full Text] [Related]
34. Auto-antibodies in multiple sclerosis: an hypothesis.
Waegemans T
Biomed Pharmacother; 2004 Jun; 58(5):282-5. PubMed ID: 15194163
[No Abstract] [Full Text] [Related]
35. [Blood and cerebrospinal fluid test in multiple sclerosis].
Mori M
Nihon Rinsho; 2015 Sep; 73 Suppl 7():150-7. PubMed ID: 26480693
[No Abstract] [Full Text] [Related]
36. An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis.
Lolli F; Mulinacci B; Carotenuto A; Bonetti B; Sabatino G; Mazzanti B; D'Ursi AM; Novellino E; Pazzagli M; Lovato L; Alcaro MC; Peroni E; Pozo-Carrero MC; Nuti F; Battistini L; Borsellino G; Chelli M; Rovero P; Papini AM
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10273-8. PubMed ID: 16014416
[TBL] [Abstract][Full Text] [Related]
37. Multiple sclerosis: KIR4.1 as an autoantigen in MS--new questions raised.
Killock D
Nat Rev Neurol; 2014 Aug; 10(8):426. PubMed ID: 25048658
[No Abstract] [Full Text] [Related]
38. [Significance of neutralizing antibodies to immunomodulatory therapy and their laboratory analysis in multiple sclerosis].
Seres E; Vécsei L
Ideggyogy Sz; 2006 May; 59(5-6):156-62. PubMed ID: 16786710
[TBL] [Abstract][Full Text] [Related]
39. [Immunologic tests: Myelin basic protein and anti-myelin basic protein antibody].
Ohta M; Ohta K
Nihon Rinsho; 2005 Jul; 63 Suppl 7():596-8. PubMed ID: 16111342
[No Abstract] [Full Text] [Related]
40. Fmoc-protected iminosugar modified asparagine derivatives as building blocks for glycomimetics-containing peptides.
Nuti F; Paolini I; Cardona F; Chelli M; Lolli F; Brandi A; Goti A; Rovero P; Papini AM
Bioorg Med Chem; 2007 Jun; 15(12):3965-73. PubMed ID: 17459712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
